Literature DB >> 21160203

Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease.

Oktay Tutarel1, Agnieszka Denecke, Stefanie M Bode-Böger, Jens Martens-Lobenhoffer, Bernhard Schieffer, Mechthild Westhoff-Bleck, Jan T Kielstein.   

Abstract

BACKGROUND/AIMS: Adults with congenital heart disease exhibit a 3-fold higher mortality in the presence of chronic kidney disease, hence assessment of renal function is crucial in this patient population. Formulas for the estimation of glomerular filtration rate (GFR) have not been evaluated in this patient population. Therefore, this study compares different markers and equations for the estimation of renal function in adults with congenital heart disease.
METHODS: Renal function was assessed in 102 patients using the Modification of Diet in Renal Disease (MDRD) equation, the simplified MDRD equation, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the Cockcroft-Gault formula. Additionally, symmetrical dimethylarginine (SDMA) was measured. Those parameters were compared to cystatin C-derived GFR using the Larsson equation.
RESULTS: GFR estimates using the original MDRD (r = 0.465, p < 0.001) and the CKD-EPI equation (r = 0.462, p < 0.001) showed a similar strong correlation with the cystatin C-based eGFR equation, while eGFR using the simplified MDRD equation showed a slightly weaker correlation (r = 0.439, p < 0.001). The Cockcroft-Gault formula showed no correlation at all to the cystatin C-based eGFR (r = 0.144, p = 0.17). The strongest correlation was observed for SDMA and cystatin C-based eGFR (r = -0.552, p < 0.001).
CONCLUSION: GFR in adults with congenital heart disease should be estimated using the original MDRD or the CKD-EPI formula. SDMA seems to be a promising marker of renal function for this patient group.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160203     DOI: 10.1159/000322614

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  13 in total

1.  Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.

Authors:  Eva Schepers; Daniela V Barreto; Sophie Liabeuf; Griet Glorieux; Sunny Eloot; Fellype C Barreto; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

2.  Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Authors:  Charles T Quinn; Santosh L Saraf; Victor R Gordeuk; Courtney D Fitzhugh; Susan E Creary; Prasad Bodas; Alex George; Ashok B Raj; Alecia C Nero; Catherine E Terrell; Lisa McCord; Adam Lane; Hans C Ackerman; Yu Yang; Omar Niss; Michael D Taylor; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

3.  [Pharmacotherapy in patients suffering from chronic kidney disease].

Authors:  J T Kielstein; F Keller
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

4.  Renal dysfunction is common among adults after palliation for previous tetralogy of Fallot.

Authors:  Matthew W Buelow; Aaron Dall; Peter J Bartz; James S Tweddell; Jane Sowinski; Nancy Rudd; Lindsey Katzmark; Michael G Earing
Journal:  Pediatr Cardiol       Date:  2012-06-07       Impact factor: 1.655

5.  Cardiac Troponin I elevation after epileptic seizure.

Authors:  Nicole Sieweke; Jens Allendörfer; Wolfgang Franzen; Andreas Feustel; Frank Reichenberger; Wolfgang Pabst; Heidrun Heidi Krämer; Manfred Kaps; Christian Tanislav
Journal:  BMC Neurol       Date:  2012-07-17       Impact factor: 2.474

6.  Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease.

Authors:  Christian Tanislav; Dursun Guenduez; Christoph Liebetrau; Anne Kathrin Giese; Sabrina Eichler; Nicole Sieweke; Maria Speth; Timm Bauer; Christian Hamm; Arndt Rolfs
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

7.  Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.

Authors:  Aleksandra Jaźwińska-Kozuba; Jens Martens-Lobenhoffer; Andrzej Surdacki; Olga Kruszelnicka; Jarosław Rycaj; Urszula Godula-Stuglik; Stefanie M Bode-Böger
Journal:  Int J Mol Sci       Date:  2012-11-21       Impact factor: 5.923

8.  Continuous cardiac troponin I release in Fabry disease.

Authors:  Andreas Feustel; Andreas Hahn; Christian Schneider; Nicole Sieweke; Wolfgang Franzen; Dursun Gündüz; Arndt Rolfs; Christian Tanislav
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

9.  Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA.

Authors:  Jente Boelaert; Eva Schepers; Griet Glorieux; Sunny Eloot; Raymond Vanholder; Frédéric Lynen
Journal:  Toxins (Basel)       Date:  2016-05-13       Impact factor: 4.546

Review 10.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.